Company / Capital Expenditures
Zimmer Biomet Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$224.5M
FY2025
5-year range
$143.6M / $291.1M
FY2021-FY2025
Trend
+10.2%
vs FY2024
Sector context
#40 of 151
Health Care
What the data says
At $225M, Zimmer Biomet's capital expenditures ranks #40 of 151 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $112M in FY2020 to $291M in FY2023.
Based on SEC 10-K filings.
$225M in FY2025 with a 5-year CAGR of +14.9%.
Declined from $291M to $225M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +6.1%
- 5-Year CAGR
- +14.9%
- 10-Year CAGR
- -
Sector benchmark
#40 of 151 in Health CareTop 26% of 151This company $224.5M Sector average $271.7M
▼
-17.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +14.9%, indicating consistent growth.
- In FY2025, capital expenditures increased 10.2% year-over-year.
- Ranks #40 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $224.5M | +10.2% |
| FY2024 | $203.8M | -30.0% |
| FY2023 | $291.1M | +54.9% |
| FY2022 | $187.9M | +30.8% |
| FY2021 | $143.6M | +28.3% |
| FY2020 | $111.9M | -28.3% |
| FY2019 | $156.0M | -15.5% |
| FY2018 | $184.7M | +18.4% |
| FY2017 | $156.0M | +7.7% |
| FY2016 | $144.9M | -13.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026